Ascendis Pharma

ASND | NASDAQ | 0 Followers
$160.05 +1.23% $1.95
Follow
Overview Metrics Financials
Loading...

Fair Price

$643.74
Overvalued by 79.7%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Ascendis Pharma A/S is a Danish biotechnology company focused on the development and commercialization of therapeutic solutions for rare diseases and endocrine disorders. Founded in 2006, its innovative approach utilizes the proprietary TransCon™ technology, enabling targeted and long-acting drug delivery. The company specializes in developing medications that provide continuous release of active ingredients into the body, improving effectiveness and patient convenience. Its main therapeutic areas include growth hormone disorders, hypoparathyroidism, and other endocrine diseases. Ascendis Pharma has a global reach, with its products in various stages of clinical development.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade